Found: 31
Select item for more details and to access through your institution.
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1568, doi. 10.1007/s10637-021-01120-7
- By:
- Publication type:
- Article
Chemoprevention of pancreatic cancer by inhibition of glutathione-S transferase P1.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1484, doi. 10.1007/s10637-021-01129-y
- By:
- Publication type:
- Article
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 152, doi. 10.1007/s10637-020-00942-1
- By:
- Publication type:
- Article
A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 307, doi. 10.1007/s10637-016-0422-z
- By:
- Publication type:
- Article
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11560-4
- By:
- Publication type:
- Article
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A Retroperitoneal Sympathetic Paraganglioma Invading the Duodenum and Mimicking a Submucosal Tumor.
- Published in:
- Endocrine Pathology, 2008, v. 19, n. 2, p. 128, doi. 10.1007/s12022-008-9025-3
- By:
- Publication type:
- Article
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 2, p. 501, doi. 10.1007/s10549-018-4853-4
- By:
- Publication type:
- Article
Thrombocytosis as a prognostic factor in inflammatory breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 3, p. 819, doi. 10.1007/s10549-017-4463-6
- By:
- Publication type:
- Article
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 407, doi. 10.1007/s10549-015-3436-x
- By:
- Publication type:
- Article
Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy.
- Published in:
- Oncology, 2012, v. 82, n. 5, p. 298, doi. 10.1159/000336792
- By:
- Publication type:
- Article
Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 330, doi. 10.1002/jvc2.119
- By:
- Publication type:
- Article
The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study.
- Published in:
- Cancer Reports, 2023, v. 6, n. 2, p. 1, doi. 10.1002/cnr2.1695
- By:
- Publication type:
- Article
A patient with paroxysmal nocturnal haemoglobinuria in whom granulocyte colony-stimulating factor administration resulted in improvement of recurrent enterocolitis and its associated haemolytic attacks.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 3, p. 858, doi. 10.1046/j.1365-2141.2002.03914.x
- By:
- Publication type:
- Article
Current Status of Advance Care Planning and End‐of‐life Communication for Patients with Advanced and Metastatic Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e686, doi. 10.1002/onco.13640
- By:
- Publication type:
- Article
Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e909, doi. 10.1634/theoncologist.2018-0611
- By:
- Publication type:
- Article
High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 21, doi. 10.1634/theoncologist.2015-0101
- By:
- Publication type:
- Article
Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1216813
- By:
- Publication type:
- Article
Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72661-9
- By:
- Publication type:
- Article
Efficacy and Feasibility of Combination Chemotherapy with S-1 and Cisplatin (2 Weeks Regimen) for Advanced Gastric Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 4, p. 302, doi. 10.1093/jjco/hyp177
- By:
- Publication type:
- Article
Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series.
- Published in:
- IJU Case Reports, 2019, v. 2, n. 3, p. 150, doi. 10.1002/iju5.12066
- By:
- Publication type:
- Article
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 6, p. 3, doi. 10.1186/bcr3579
- By:
- Publication type:
- Article
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy.
- Published in:
- In Vivo, 2021, v. 35, n. 2, p. 1041, doi. 10.21873/invivo.12348
- By:
- Publication type:
- Article
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01473-2
- By:
- Publication type:
- Article
Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 1, p. 37, doi. 10.1016/j.clbc.2014.06.007
- By:
- Publication type:
- Article
Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer.
- Published in:
- Case Reports in Oncological Medicine, 2020, p. 1, doi. 10.1155/2020/7231358
- By:
- Publication type:
- Article
Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 924, doi. 10.1111/cas.14306
- By:
- Publication type:
- Article